Advertisement
Screener

COMPLETE GENOMICS INC Investing Cash Flow

COMPLETE GENOMICS INC Investing Cash Flow

COMPLETE GENOMICS INC reported Investing Cash Flow of -$2.94 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2012-11-09

  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for the quarter ending 2012-09-30 was $2.50M.
  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for the quarter ending 2012-06-30 was $9.36M.
  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for the quarter ending 2012-03-31 was -$14.80M.
  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for the quarter ending 2011-12-31 was $28.87M.
  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for fiscal 2011 was -$27.14M.
  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for fiscal 2010 was -$18.80M.
  • COMPLETE GENOMICS INC net cash provided by (used in) investing activities for fiscal 2009 was -$9.65M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2012-09-30$2.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$11.86M
derived: sum of 2 quarters · filed 2012-11-09
-$2.94M
10-Q · filed 2012-11-09
$25.93M
derived: sum of 4 quarters · filed 2012-11-09
2012-06-30$9.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$5.44M
10-Q · filed 2012-08-09
$23.43M
derived: sum of 3 quarters · filed 2012-08-09
$19.14M
derived: sum of 4 quarters · filed 2012-11-09
2012-03-31-$14.80M
10-Q · filed 2012-05-09
$14.07M
derived: sum of 2 quarters · filed 2012-05-09
$9.78M
derived: sum of 3 quarters · filed 2012-11-09
-$38.83M
derived: sum of 4 quarters · filed 2012-11-09
2011-12-31$28.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09
$24.58M
derived: sum of 2 quarters · filed 2012-11-09
-$24.02M
derived: sum of 3 quarters · filed 2012-11-09
-$27.14M
10-K · filed 2012-03-09
2011-09-30-$4.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$52.90M
derived: sum of 2 quarters · filed 2012-11-09
-$56.02M
10-Q · filed 2012-11-09
-$56.78M
derived: sum of 4 quarters · filed 2012-11-09
2011-06-30-$48.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$51.73M
10-Q · filed 2012-08-09
-$52.49M
derived: sum of 3 quarters · filed 2012-08-09
-$54.83M
derived: sum of 4 quarters · filed 2012-08-09
2011-03-31-$3.12M
10-Q · filed 2012-05-09
-$3.88M
derived: sum of 2 quarters · filed 2012-05-09
-$6.22M
derived: sum of 3 quarters · filed 2012-05-09
2010-12-31-$762.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09
-$3.10M
derived: sum of 2 quarters · filed 2012-03-09
-$18.80M
10-K · filed 2012-03-09
2010-09-30-$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$18.04M
10-Q · filed 2011-11-14
2010-06-30-$15.70M
10-Q · filed 2011-08-15
2009-12-31-$9.65M
10-K · filed 2012-03-09